Objectives: To evaluate outcomes of patients achieving a post-treatment pathological stage of

Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration / Ravi, P., Pond, G.R., Diamantopoulos, L.N., Su, C., Alva, A., Jain, R.K., Skelton, W.P., Gupta, S., Tward, J.D., Olson, K.M., Singh, P., Grunewald, C.M., Niegisch, G., Lee, J.-L., Gallina, A., Bandini, M., Necchi, A., Mossanen, M., Mcgregor, B.A., Curran, C., et al.. - In: BJU INTERNATIONAL. - ISSN 1464-4096. - (2021). [10.1111/bju.15434]

Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration

Bandini M.;Necchi A.;
2021-01-01

Abstract

Objectives: To evaluate outcomes of patients achieving a post-treatment pathological stage of
2021
#BladderCancer
#blcsm
bladder cancer
neoadjuvant chemotherapy
pathological response
recurrence
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/118323
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 27
social impact